Plasma phospholipid fatty acid content is related to disease activity in ankylosing spondylitis

Journal of Rheumatology

Volumn 39, Issue 2, 2012, Pages 327-333

  Sundström, Björn ^a   Johansson, Gunnar ^b   Kokkonen, Heidi ^c   Cederholm, Tommy ^c   Wållberg Jonsson, Solveig ^c  

^a UMEÅ UNIVERSITY   (Sweden)

^b HALMSTAD UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Ankylosing spondylitis; Diet; Disease activity; Fatty acids

Indexed keywords

ARACHIDONIC ACID; C REACTIVE PROTEIN; CYTOKINE; FATTY ACID; HIGH DENSITY LIPOPROTEIN; LONG CHAIN FATTY ACID; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; FAT INTAKE; FEMALE; FOOD ANALYSIS; FOOD COMPOSITION; FOOD FREQUENCY QUESTIONNAIRE; GAS CHROMATOGRAPHY; GLUTEUS MAXIMUS MUSCLE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; ADULT; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DIET SURVEYS; DIETARY FATS; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PHOSPHOLIPIDS; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; TRIGLYCERIDES;

EID: 84856540464     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110575     Document Type: Article

References (46)

1. Braun J, Sieper J. Ankylosing spondylitis. Lancet 2007;369:1379-90. (Pubitemid 46590387)
2. Han C, Robinson DWJ, Hackett MV, Paramore LC, Fraeman KH, Bala MV. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006;33:2167-72. (Pubitemid 44749774)
3. Mathieu S, Motreff P, Soubrier M. Spondyloarthropathies: An independent cardiovascular risk factor? Joint Bone Spine 2010;77:542-5.
4. Zochling J, van der Heijde D, Burgos-Vargas R, Collantes E, Davis JC Jr, Dijkmans B, et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2006;65:442-52.
5. Yu E. Spondyloarthropathies. Kelly's textbook of rheumatology. Philadelphia: WB Saunders Company; 2000.
6. Amor B, Dougados M, Mijiyawa M. [Criteria of the classification of spondylarthropathies]. Rev Rhum Mal Osteoartic 1990;57:85-9.
7. Ratnayake WM, Galli C. Fat and fatty acid terminology, methods of analysis and fat digestion and metabolism: A background review paper. Ann Nutr Metab 2009;55:8-43.
8. Mahan LK, Escott-Stump S. Krause's food, nutrition, and diet therapy. Philadelphia: WB Company; 1996.
9. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8. (Pubitemid 14134775)
10. Stegmayr B, Lundberg V, Asplund K. The events registration and survey procedures in the Northern Sweden MONICA Project. Scand J Public Health Suppl 2003;61:9-17.
11. Johansson I, Hallmans G, Wikman A, Biessy C, Riboli E, Kaaks R. Validation and calibration of food-frequency questionnaire measurements in the Northern Sweden Health and Disease cohort. Public Health Nutr 2002;5:487-96. (Pubitemid 34614917)
12. Wennberg M, Vessby B, Johansson I. Evaluation of relative intake of fatty acids according to the Northern Sweden FFQ with fatty acid levels in erythrocyte membranes as biomarkers. Public Health Nutr 2009;12:1477-84.
13. Bergström L, Hagman U, Eriksson H, Bruce Å. The food composition data base system (KOST systemet) - Its use for nutrient values [Swedish]. Vår Föda 1991;43:439-47.
14. Waldner A, Cronstedt H, Stenstrom CH. The Swedish version of the Bath Ankylosing Spondylitis Disease Activity Index. Reliability and validity. Scand J Rheumatol Suppl 1999;111:10-6. (Pubitemid 29419527)
15. Cronstedt H, Waldner A, Stenstrom CH. The Swedish version of the Bath Ankylosing Spondylitis Functional Index. Reliability and validity. Scand J Rheumatol Suppl 1999;111:1-9. (Pubitemid 29419526)
16. Johansson G, Westerterp KR. Assessment of the physical activity level with two questions: Validation with doubly labeled water. Int J Obes 2008;32:1031-3. (Pubitemid 351986228)
17. Togrol RE, Nalbant S, Solmazgul E, Ozyurt M, Kaplan M, Kiralp MZ, et al. The significance of coeliac disease antibodies in patients with ankylosing spondylitis: A case-controlled study. J Int Med Res 2009;37:220-6.
18. Lange U, Jung O, Teichmann J, Neeck G. Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis. Osteoporos Int 2001;12:1031-5. (Pubitemid 34105974)
19. Beynen AC, Katan MB. Rapid sampling and long-term storage of subcutaneous adipose-tissue biopsies for determination of fatty acid composition. Am J Clin Nutr 1985;42:317-22. (Pubitemid 16246364)
20. Boberg M, Croon LB, Gustafsson IB, Vessby B. Platelet fatty acid composition in relation to fatty acid composition in plasma and to serum lipoprotein lipids in healthy subjects with special reference to the linoleic acid pathway. Clin Sci 1985;68:581-7. (Pubitemid 15103439)
21. Wanders A, Heijde D, Landewe R, Behier JM, Calin A, Olivieri I, et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: A randomized clinical trial. Arthritis Rheum 2005;52:1756-65. (Pubitemid 40852884)
22. Bonewald LF. Mechanosensation and transduction in osteocytes. Bonekey Osteovision 2006;3:7-15.
23. Raisz LG. Physiologic and pathologic roles of prostaglandins and other eicosanoids in bone metabolism. J Nutr 1995;125:2024S-7S.
24. Poulsen RC, Moughan PJ, Kruger MC. Long-chain polyunsaturated fatty acids and the regulation of bone metabolism. Exp Biol Med 2007;232:1275-88. (Pubitemid 350014417)
25. Maniongui C, Blond JP, Ulmann L, Durand G, Poisson JP, Bezard J. Age-related changes in delta 6 and delta 5 desaturase activities in rat liver microsomes. Lipids 1993;28:291-7. (Pubitemid 23111154)
26. Hrelia S, Bordoni A, Celadon M, Turchetto E, Biagi PL, Rossi CA. Age-related changes in linoleate and alpha-linolenate desaturation by rat liver microsomes. Biochem Biophys Res Commun 1989;163:348-55. (Pubitemid 19227312)
27. Horrobin DF. Essential fatty acids, prostaglandins, and alcoholism: An overview. Alcohol Clin Exp Res 1987;11:2-9. (Pubitemid 17041815)
28. Burdge GC, Wootton SA. Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr 2002;88:411-20. (Pubitemid 35251957)
29. Esteve-Comas M, Ramirez M, Fernandez-Banares F, Abad-Lacruz A, Gil A, Cabre E, et al. Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease. Gut 1992;33:1365-9.
30. Esteve-Comas M, Nunez MC, Fernandez-Banares F, Abad-Lacruz A, Gil A, Cabre E, et al. Abnormal plasma polyunsaturated fatty acid pattern in non-active inflammatory bowel disease. Gut 1993;34:1370-3. (Pubitemid 23293621)
31. Vahlquist C, Berne B, Boberg M, Michaelsson G, Vessby B. The fatty-acid spectrum in plasma and adipose tissue in patients with psoriasis. Arch Dermatol Res 1985;278:114-9. (Pubitemid 16205551)
32. Martinelli N, Girelli D, Malerba G, Guarini P, Illig T, Trabetti E, et al. FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. Am J Clin Nutr 2008;88:941-9.
33. Merino DM, Ma DW, Mutch DM. Genetic variation in lipid desaturases and its impact on the development of human disease. Lipids Health Dis 2010;9:63.
34. Harnack K, Andersen G, Somoza V. Quantitation of alpha-linolenic acid elongation to eicosapentaenoic and docosahexaenoic acid as affected by the ratio of n6/n3 fatty acids. Nutr Metab 2009;6:8.
35. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006;83:1505S-19S. (Pubitemid 44713092)
36. Barham JB, Edens MB, Fonteh AN, Johnson MM, Easter L, Chilton FH. Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans. J Nutr 2000;130:1925-31. (Pubitemid 30497522)
37. Sundström B, Stålnacke K, Hagfors L, Johansson G. Supplementation of omega-3 fatty acids in patients with ankylosing spondylitis. Scand J Rheumatol 2006;35:359-62. (Pubitemid 44601069)
38. Cleland LG, James MJ, Proudman SM. Fish oil: What the prescriber needs to know. Arthritis Res Ther 2006;8:202.
39. Galli C, Calder PC. Effects of fat and fatty acid intake on inflammatory and immune responses: A critical review. Ann Nutr Metab 2009;55:123-39.
40. Lairon D. Intervention studies on Mediterranean diet and cardiovascular risk. Mol Nutr Food Res 2007;51:1209-14. (Pubitemid 350013168)
41. Bremander A, Petersson I, Bergman S, Englund M. Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res 2011;63:550-6.
42. Sundstrom B, Wallberg-Jonsson S, Johansson G. Diet, disease activity, and gastrointestinal symptoms in patients with ankylosing spondylitis. Clin Rheumatol 2010;30:71-6.
43. Kiortsis DN, Mavridis AK, Filippatos TD, Vasakos S, Nikas SN, Drosos AA. Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 2006;33:921-3.
44. Svensk reumatologisk förening [The Swedish Society of Rheumatology]. [Internet. Accessed Oct 13, 2011.] Available from: http://www. svenskreumatologi.se/Riktlinjer/SRFs%20riktlinjer-AS%20och%20PsoA-2011.pdf
45. Braun J, Pham T, Sieper J, Davis J, van der Linden S, Dougados M, et al. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 2003;62:817-24. (Pubitemid 37026490)
46. Cohen JD, Cunin P, Farrenq V, Oniankitan O, Carton L, Chevalier X, et al. Estimation of the Bath Ankylosing Spondylitis Disease Activity Index cutoff for perceived symptom relief in patients with spondyloarthropathies. J Rheumatol 2006;33:79-81. (Pubitemid 43054284)